Early Life Interventions for Childhood Growth and Development In Tanzania
Status:
Completed
Trial end date:
2020-03-26
Target enrollment:
Participant gender:
Summary
This study aims to assess growth and cognitive effects of treatment with azithromycin and
nitazoxanide and/or nicotinamide (vitamin B3) supplementation nicotinamide.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Haydom Lutheran Hospital
Collaborators:
Bill and Melinda Gates Foundation University of Virginia